Accelerating EU research for rare diseases – the case of pulmonary hypertension

Pulmonary hypertension (PH) is a rare condition that affects about 15 to 50 people out of every million. Although it cannot be cured, in the past decade great improvements have been made in the understanding of PH, but there remain many opportunities for further research in this area.

Ahead of the upcoming World PH Day (5 May), the MEP Lung Health Group hosted the free webinar, “Accelerating EU research for rare diseases – the case of pulmonary hypertension” on 21 April, 2021.

The webinar features presentations that showcase how EU research has led to successes in the field of PH. The presentations are followed by a virtual roundtable discussion, wherein expert panellists discuss how to further accelerate EU research on rare diseases, to strive for more breakthroughs in this area.

MEP Lung Health Group event